↓ Skip to main content

SRC and MEK Co-inhibition Synergistically Enhances the Anti-tumor Effect in Both Non-small-cell Lung Cancer (NSCLC) and Erlotinib-Resistant NSCLC

Overview of attention for article published in Frontiers in oncology, July 2019
Altmetric Badge

Mentioned by

twitter
1 X user
reddit
1 Redditor

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
19 Mendeley